Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

…, MM Levy, A Rhodes, D Annane, H Gerlach… - Critical care …, 2013 - journals.lww.com
Objective: To provide an update to the “Surviving Sepsis Campaign Guidelines for
Management of Severe Sepsis and Septic Shock,” last published in 2008. Design: A consensus …

[HTML][HTML] Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016

…, CJ French, S Fujishima, H Gerlach… - Intensive care …, 2017 - Springer
Objective To provide an update to “Surviving Sepsis Campaign Guidelines for Management
of Sepsis and Septic Shock: 2012”. Design A consensus committee of 55 international …

[HTML][HTML] The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis

…, G Ramsay, R Beale, MM Parker, H Gerlach… - Intensive care …, 2010 - Springer
Objective The Surviving Sepsis Campaign (SSC or “the Campaign”) developed guidelines
for management of severe sepsis and septic shock. A performance improvement initiative …

Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study

…, HD Volk, WD Doecke, KJ Falke, H Gerlach - American Journal of …, 2003 - atsjournals.org
Within the last few years, increasing evidence of relative adrenal insufficiency in septic
shock evoked a reassessment of hydrocortisone therapy. To evaluate the effects of …

Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial

…, C Putensen, G Elke, M Ragaller, H Gerlach… - JAMA internal …, 2016 - jamanetwork.com
Importance High-dose intravenous administration of sodium selenite has been proposed to
improve outcome in sepsis by attenuating oxidative stress. Procalcitonin-guided …

Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial

…, S Bercker, H Bogatsch, J Briegel, C Engel, H Gerlach… - Jama, 2016 - jamanetwork.com
Importance Adjunctive hydrocortisone therapy is suggested by the Surviving Sepsis Campaign
in refractory septic shock only. The efficacy of hydrocortisone in patients with severe …

The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials

…, C Hartog, K Reinhart, S Kokkoris, H Gerlach… - Critical care …, 2013 - journals.lww.com
Background: Patients with sepsis syndrome commonly have low serum selenium levels.
Several randomized controlled trials have examined the efficacy of selenium supplementation …

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

…, T Calandra, JF Dhainaut, H Gerlach… - Critical care …, 2008 - journals.lww.com
Objective: To provide an update to the original Surviving Sepsis Campaign clinical management
guidelines,“Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis …

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

RP Dellinger, JM Carlet, H Masur, H Gerlach… - Critical care …, 2004 - journals.lww.com
Objective In 2003, critical care and infectious disease experts representing 11 international
organizations developed management guidelines for severe sepsis and septic shock that …

Sepsis in European intensive care units: results of the SOAP study

…, VM Ranieri, K Reinhart, H Gerlach… - Critical care …, 2006 - journals.lww.com
Objective: To better define the incidence of sepsis and the characteristics of critically ill
patients in European intensive care units. Design: Cohort, multiple-center, observational study. …